Survival presented with Kaplan-Meier curves, and analyzed using the logrank test, for disease-specific survival (DSS) in patients with HPV-positive oropharyngeal squamous cell carcinoma (HPV<sub>DNA</sub>+ OSCC) with known HLA class I intensity and different treatment regimes.
- Anders Näsman (167962)
- Emilia Andersson (303022)
- Linda Marklund (319689)
- Nikolaos Tertipis (382917)
- Lalle Hammarstedt-Nordenvall (469217)
- Per Attner (469218)
- Tommy Nyberg (469219)
- Giuseppe V. Masucci (469220)
- Eva Munck-Wikland (319690)
- Torbjörn Ramqvist (167977)
- Tina Dalianis (167974)
DOIAbstract
<p>(A) DSS in HPV<sub>DNA</sub>+ OSCC with absent HCA-2 intensity stratified for radiotherapy (RT) and induction chemotherapy-RT, (B) DSS in HPV<sub>DNA</sub>+ OSCC with weak HCA-2 intensity stratified for radiotherapy (RT) and induction chemotherapy-RT, (C) DSS in HPV<sub>DNA</sub>+ OSCC with strong HCA-2 intensity stratified for radiotherapy (RT) and induction chemotherapy-RT, (D) DSS in HPV<sub>DNA</sub>+ OSCC with absent HC-10 intensity stratified for radiotherapy (RT) and induction chemotherapy-RT, (E) DSS in HPV<sub>DNA</sub>+ OSCC with weak HC-10 intensity stratified for radiotherapy (RT) and induction chemotherapy-RT, (F) DSS in HPV<sub>DNA</sub>+ OSCC with strong HC-10 intensity stratified for radiotherapy (RT) and induction chemot...
Add to ORKG